| 
									 	8:00 am	 
								 | 
								
										Registration, Continental Breakfast and View Exhibits	 
											
								 | 
			
								| 
									 	9:00 am 	 
								 | 
								
										Welcome and Introduction	 
										Ossama Lashin, MD, PhD and Joyce Shin, MD	
								 | 
			
								| 
									 	9:10 am 	 
								 | 
								
										2024 Guidelines for Evaluation and Management of Thyroid Nodules	 
										Lea El Hage, MD 	
								 | 
			
								| 
									 	9:40 am	 
								 | 
								
										Updates of the 2022 WHO Classification of Thyroid Neoplasms and 2023 Bethesda System for Reporting Thyroid Cytopathology	 
										Tarik Elsheikh, MD	
								 | 
			
								| 
									 	10:10 am 	 
								 | 
								
										Laboratory Testing Advances in Thyroid Disorders	 
										Jessica Colon-Franco, PhD 	
								 | 
			
								| 
									 	10:40 am 	 
								 | 
								
										Morning Refreshment Break and View Exhibits	 
											
								 | 
			
								| 
									 	11:00 am	 
								 | 
								
										Advances in the Management of Thyroid Cancer	 
										R. Michael Tuttle, MD	
								 | 
			
								| 
									 	12:00 pm 	 
								 | 
								
										Lunch	 
											
								 | 
			
								| 
									 	1:00 pm	 
								 | 
								
										Advanced Thyroid Cancer: Molecularly Driven Systemic Therapy	 
										Jessica Geiger, MD	
								 | 
			
								| 
									 	1:30 pm	 
								 | 
								
										Insights into the Pathophysiology and New Recommendations for the Management of Thyroid Eye Disease	 
										Terry J. Smith, MD	
								 | 
			
								| 
									 	2:30 pm	 
								 | 
								
										Recent New Technologies on Thyroid Surgery 	 
										Eren Berber, MD	
								 | 
			
								| 
									 	3:00 pm	 
								 | 
								
										Afternoon Refreshment Break and View Exhibits	 
											
								 | 
			
								| 
									 	3:20 pm	 
								 | 
								
										Case Session/Panel Discussion	 
										Allan Siperstein, MD	
								 | 
			
								| 
									 	4:20 pm	 
								 | 
								
										Closing Remarks/Adjourn	 
											
								 | 
			
                | A five minute question and answer period is included in each speaker’s allotted time. |